The global prevalence of allergic rhinitis (AR) remains high, posing challenges due to its chronic nature and propensity for recurrence. Gut microbiota dysbiosis contributes to immune dysregulation, impacting AR pathogenesis. () has great potential in regulating immune function to alleviate AR symptoms. However, the specific active components and mechanisms underlying its therapeutic effects in AR remain incompletely clarified. This study aimed to explore the potential mechanisms of and its metabolites in alleviating AR. The AR mouse model was constructed using ovalbumin (OVA). The analysis of hematoxylin-eosin staining (HE staining) and enzyme-linked immunosorbent assay (ELISA) suggested that alleviated nasal inflammation, suppressed aberrant Th2 immune responses, and modulated the balance of Treg and Th17 cytokines. The 16S rRNA sequencing and untargeted metabolic analysis revealed that restored gut microbiota composition and significantly increased the abundance of and the metabolite luteolin (LO). Through ELISA and Western blotting analysis, LO treatment restored the Th1/Th2 and Treg/Th17 cytokine balance and suppressed the MAPK/STAT3 signaling pathway in AR mice. The study highlights LO as a key metabolite contributing to the anti-inflammatory effects of , suggesting potential avenues for future therapeutic strategies in AR management.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11891226 | PMC |
http://dx.doi.org/10.3389/fmicb.2025.1522191 | DOI Listing |
Am J Chin Med
March 2025
School of Public Health, Nantong University, 9 Seyuan Road, Nantong, Jiangsu 226019, P. R. China.
Ulcerative colitis (UC) is a chronic, nonspecific inflammatory disorder characterized by symptoms such as abdominal pain, diarrhea, hematochezia, and urgency during defecation. While the primary site of involvement is the colon, UC can extend to encompass the entire rectum and colon. The causes and development mechanisms of UC are still not well understood; nonetheless, it is currently held that factors including environmental influences, genetic predispositions, intestinal mucosal integrity, gut microbiota composition, and immune dysregulation contribute to its development.
View Article and Find Full Text PDFFront Immunol
March 2025
Changchun University of Chinese Medicine, Changchun, China.
In recent years, tumor immunotherapy has made significant breakthroughs in the treatment of malignant tumors. However, individual differences in efficacy have been observed in clinical practice. There is increasing evidence that gut microbial metabolites influence the efficacy of distal tumor immunotherapy via the gut-liver axis, the gut-brain axis and the gut-breast axis, a process that may involve modulating the expression of immune cells and cytokines in the tumor microenvironment (TME).
View Article and Find Full Text PDFGastroenterol Rep (Oxf)
March 2025
Department of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, P. R. China.
Background: Liver fibrosis is characterized by hepatic stellate cell (HSC) activation and collagen overproduction, but its pathogenesis remains largely unknown. This study aimed to uncover the role of neural precursor cell expressed developmentally downregulated 4-like (Nedd4L) signaling in liver fibrosis and its relationship with gut microbiota.
Methods: Intraperitoneal injection of carbon tetrachloride (CCl) was used to induce liver fibrosis in 8-week-old female C57BL/6J mice with knockout or administration of the Nedd4L protein phosphorylation inhibitor EMD638683.
Front Microbiol
February 2025
Department of Biomedical Sciences, Institute of Health, Jimma University, Jimma, Ethiopia.
The COVID-19 pandemic underscored bacterial resistance as a critical global health issue, exacerbated by the increased use of antibiotics during the crisis. Notwithstanding the pandemic's prevalence, initiatives to address bacterial medication resistance have been inadequate. Although an overall drop in worldwide antibiotic consumption, total usage remains substantial, requiring rigorous regulatory measures and preventive activities to mitigate the emergence of resistance.
View Article and Find Full Text PDFFront Microbiol
February 2025
Jinling Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
The global prevalence of allergic rhinitis (AR) remains high, posing challenges due to its chronic nature and propensity for recurrence. Gut microbiota dysbiosis contributes to immune dysregulation, impacting AR pathogenesis. () has great potential in regulating immune function to alleviate AR symptoms.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!